Applied DNA Sciences (NASDAQ:APDN) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Applied DNA Sciences (NASDAQ:APDN) in a report issued on Sunday. The brokerage issued a sell rating on the technology company’s stock.

Separately, HC Wainwright decreased their target price on shares of Applied DNA Sciences from $7.00 to $1.50 and set a buy rating for the company in a research note on Monday, June 10th.

Applied DNA Sciences Stock Performance

Shares of APDN stock opened at $0.47 on Friday. Applied DNA Sciences has a one year low of $0.33 and a one year high of $37.20. The company has a 50 day moving average price of $1.43 and a 200 day moving average price of $7.22. The firm has a market capitalization of $455,700.00, a price-to-earnings ratio of -0.03 and a beta of 0.08.

Applied DNA Sciences (NASDAQ:APDN) last released its quarterly earnings data on Friday, May 10th. The technology company reported ($5.31) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.60) by ($0.71). Applied DNA Sciences had a negative return on equity of 306.32% and a negative net margin of 222.33%. The business had revenue of $0.93 million for the quarter, compared to analysts’ expectations of $0.90 million. As a group, equities analysts forecast that Applied DNA Sciences will post -2.95 EPS for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC bought a new position in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned 0.72% of Applied DNA Sciences as of its most recent filing with the Securities and Exchange Commission (SEC). 22.22% of the stock is owned by institutional investors.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.